Zalutumumab
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for Zalutumumab, covering 2011-10-10 to 2016-11-25. Get the full timeline:
Most recent: Clinical Trial Update: DAHANCA 19: The Importance of the EGFr-inhibitor Zalutumumab for the Outcome After Curative Radiotherapy for HNSCC [Phase 3]